Form 8-K - Current report:
SEC Accession No. 0000939767-23-000003
Filing Date
2023-01-09
Accepted
2023-01-09 16:15:04
Documents
15
Period of Report
2023-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20230108.htm   iXBRL 8-K 34369
2 EX-99.1 a230108corporatepriorities.htm EX-99.1 64099
6 exel-20230108_g1.jpg GRAPHIC 116418
7 image_0.jpg GRAPHIC 10621
  Complete submission text file 0000939767-23-000003.txt   520585

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20230108.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20230108_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20230108_pre.xml EX-101.PRE 12520
9 EXTRACTED XBRL INSTANCE DOCUMENT exel-20230108_htm.xml XML 10719
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 23518243
SIC: 2836 Biological Products, (No Diagnostic Substances)